References
- Ad Age. (2011). Pharmaceutical marketing. Retrieved from http://adage.com/images/bin/pdf/WPpharmmarketing_revise.pdf
- Aikin, K. J., Swasy, J. L., & Braman, A. C. (2004). Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs: Summary of FDA survey research results. Retrieved from http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/DrugMarketingAdvertisingandCommunicationsResearch/ucm151498.htm
- Alperstein, N. M. (2014). Awareness of and attitudes toward direct-to-consumer prescription drug advertisements among young adults. Health Marketing Quarterly, 31, 231–245.
- Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Wiliams, M. V., & Parker, R. M. (2004). Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9, 491–497.
- Calfee, J. E. (2002). Public policy issues in direct-to-consumer advertising of prescription drugs. Journal of Public Policy and Marketing, 21, 174–193.
- Ceccoli, S. J., & Klotz, R. J. (2013). Taking your medicine? Attitudes toward direct-to-consumer advertising (DTCA). Social Science Journal, 50, 501–509.
- Cegedim Strategic Data. (2013). 2012 U.S. pharmaceutical promotion spending. Retrieved from http://www.skainfo.com/health_care_market_reports/2012_promotional_spending.pdf
- DeLorme, D. E., Huh, J., & Reid, L. N. (2009). Direct-to-consumer advertising skepticism and the use and perceived usefulness of prescription drug information sources. Health Marketing Quarterly, 26, 293–314.
- DeLorme, D. E., Huh, J., & Reid, L. N. (2010). Evaluation, use, and usefulness of prescription drug information sources among Anglo and Hispanic Americans. Journal of Health Communication, 15,18–38.
- Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements; Notice of Agency Information Collection Activities, 79 Fed. Reg. 9,217. Retrieved from https://www.federalregister.gov/articles/2014/02/18/2014-03390/agency-information-collection-activities-proposed-collection-comment-request-disclosure-regarding
- Gilbody, S., Wilson, P., Watt, I. (2005). Benefits and harms of direct to consumer advertising: A systematic review. Quality and Safety in Health Care, 14, 246–250.
- Hollon, M. F. (2005). Direct-to-consumer advertising: A haphazard approach to health promotion. Journal of the American Medical Association, 293, 2030–2033.
- Holmer, A. F. (1999). Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Journal of the American Medical Association, 281, 380–382.
- Huh, J., DeLorme, D. E., & Reid, L. N. (2004). The information utility of DTC prescription drug advertising. Journalism and Mass Communication Quarterly, 81, 788–806.
- Huh, J., DeLorme, D. E., & Reid, L. N., & Kim, J. (2013). Korean Americans’ prescription drug information seeking and evaluation and use of different information sources. Journal of Health Communication: International Perspectives, 18, 498–526.
- Joseph, M., Spake, D. F., & Finney, Z. (2008). Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income. International Journal of Pharmaceutical and Healthcare Marketing, 2, 117–133.
- Kohut, A., Doherty, C., Dimock, M., & Keeter, S. (2012). In changing news landscape, even television is vulnerable. Retrieved from http://www.people-press.org/2012/09/27/in-changing-news-landscape-even-television-is-vulnerable/
- Kantar Media. (2013). What are adults doing as a result of healthcare advertising? Retrieved from http://www.kantarmedia-healthcare.com/what-are-adults-doing-as-a-result-of-healthcare-advertising
- Kiester, M. (2007, April). FDA update. Paper presented at the DTC National Conference, Washington, DC.
- Kiester, M. (2012, June). Draft module 1 update (1.15 promotional materials). Presented at the Meeting of the Drug Information Association, Philadelphia, PA.
- Kornfield, R., Donohue, J., Berndt, E. R., & Alexander, G. C. (2013). Promotion of prescription drugs to consumers and providers, 2001–2010. PLoS One, 8, e55504.
- Lee, D., & Begley, C. E. (2010). Racial and ethnic disparities in response to direct-to-consumer advertising. American Journal of Health-System Pharmacy, 67, 1185–1190.
- Liang, B. A., & Mackey, T. K. (2011). Prevalence and global health implications of social media in direct-to-consumer drug advertising. Journal of Medical Internet Research, 13, e64.
- Mintzes, B. (2012). Advertising of prescription-only medicines to the public: Does evidence of benefit counterbalance harm? Annual Review of Public Health, 33, 259–277.
- Mukherjee, A., Limbu, Y., & Wanasika, I. (2013). A review of research on direct-to-consumer advertising of prescription drugs: Directions for future research. International Journal of Pharmaceutical and Healthcare Marketing, 7, 226–243.
- Niedereppe, J., Byrne, S., Avery, R. J., & Cantor, J. (2013). Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin use. Journal of General Internal Medicine, 28, 886–893.
- O'Donoghue, A. C., Sullivan, H. W., Aikin, K. J., Chowdhury, D., Moultrie, R. R., & Rupert, D. J. (2013). Presenting efficacy information in direct-to-consumer prescription drug advertisements. Patient Education and Counseling, 95, 271–280.
- Pharmaceutical Research, & Manufacturers of America. (2008). PhRMA guiding principles direct to consumer advertisements about prescription medicines. Retrieved from http://phrma.org/sites/default/files/pdf/phrmaguidingprinciplesdec08final.pdf
- Polen, H. H., Khanfar, N. M., & Clauson, K. A. (2009). Impact of direct-to-consumer advertising (DTCA) on patient health-related behaviors and issues. Health Marketing Quarterly, 26, 42–55.
- Prescription Drug Advertisements, 21 C.F.R. § 202.1 (2012).
- Rakovski, C., Sparks, L., Robinson, J. D., Kee, K. F., Bevan, J. L., & Agne, R. (2012). A regression-based study using jackknife replicates of HINTS III data: Predictors of the efficacy of health information seeking. Journal of Communication in Healthcare, 5, 163–170.
- Ramanadhan, S., & Viswanath, K. (2006). Health and the information nonseeker: A profile. Health Communication, 20, 131–139.
- Schwartz, L. M., Woloshin, S., & Welch, H. G. (2007). The drug facts box: Providing consumers with simple tabular data on drug benefit and harm. Medical Decision Making, 27, 655–662.
- Schwartz, L. M., Woloshin, S., & Welch, H. G. (2009). Using a drug facts box to communicate drug benefits and harms: Two randomized trials. Annals of Internal Medicine, 150, 516–527.
- U.S. Food, & Drug Administration (FDA). (2014). For industry: Using social media. Retrieved from http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm397791.htm
- Westat. (2012). Health Information National Trends Survey 4 (HINTS 4): Cycle 1 methodology report. Retrieved from http://hints.cancer.gov/docs/HINTS4_Cycle1_Methods_Report_revised_Jun2012.pdf
- Wilbur, K. C. (2008). How the digital video recorder (DVR) changes traditional television advertising. Journal of Advertising, 37, 143–149.
- Young, H. N., Paterniti, D. A., Bell, R. A., & Kravitz, R. L. (2005). Do prescription drug advertisements educate the public? The consumer answers. Drug Information Journal, 39, 25–33.